OG
O'Neill Gilmore Neil
首席执行官
C-suiteM
内部人交易记录
首席执行官尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by O'Neill Gilmore Neil, 首席执行官. Officer active across 1 company, notably Editas Medicine, Inc.. Aggregated, 14 disclosures have been published. Split: 0 buy · 11 sells. Total volume traded: €259k. History available since 2 June 2022. The latest transaction was filed on 3 September 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to O'Neill Gilmore Neil
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
5,124 股@ US$3.0372Common StockSEC:0001742084-26-000003:0
15,380 股@ US$2.70110.0086% mcap18.8% 占其流量Common StockSEC:0001650664-26-000056:0
5,394 股@ US$2.01973.8% 占其流量Common StockSEC:0001650664-26-000009:0
5,603 股@ US$2.15314.4% 占其流量Common StockSEC:0001650664-25-000162:0
5,592 股@ US$2.59615.5% 占其流量Common StockSEC:0001650664-25-000141:0
15,192 股@ US$1.724310.8% 占其流量Common StockSEC:0001650664-25-000089:0
16,632 股@ US$1.710717.6% 占其流量Common StockSEC:0001650664-25-000026:0
1,618 股@ US$2.07742.1% 占其流量Common StockSEC:0001650664-24-000126:0
1,555 股@ US$3.42473.1% 占其流量Common StockSEC:0001650664-24-000103:0
12,191 股@ US$5.495639.9% 占其流量Common StockSEC:0001650664-24-000076:0
130,700 股0Common StockSEC:0001650664-24-000015:0
6,486 股@ US$9.503237.3% 占其流量Common StockSEC:0001415889-23-009369:0
50,000 股0Common StockSEC:0001415889-23-004313:0
86,655 股0Common StockSEC:0001415889-22-006159:0
About O'Neill Gilmore Neil
O'Neill Gilmore Neil is Directeur Général at Editas Medicine, Inc. (XNAS). He has 13 filings, all in the sampled set, with 0 in purchases and 245169 in sales, mainly disposals, over the period from 2022-06-06 to 2026-06-05.